Business · 01/02/2023
FDA Releases Draft Guidance for Externally Controlled Trials of Drug and Biological Products
The FDA is releasing a draft guidance document outlining considerations for designing and conducting externally controlled trials to support the safety and effectiveness of drug products, as part of its Real-World Evidence (RWE) Program.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →